High materiality8/10
Assembly Biosciences price target raised to $53 from $45 at Mizuho
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Mizuho Securities raises ASMB target to 53; current price 33.63; implied upside ~57%.
- Mizuho raises ASMB target to 53
- Current price 33.63; upside ~57%
Key facts
- 01
Target: $53
- 02
Posted price: $33.63
- 03
Analyst firm: Mizuho Securities
- 04
Analyst: Salim Syed
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.